Ruberoid Air Cell Pipe Insulation

Product Description

Ruberoid Air Cell was a pipe insulation product manufactured under the Ruberoid brand, which was associated with G-I Holdings and its corporate predecessors. Produced across a span of more than five decades—from 1928 through 1981—the product was designed to provide thermal insulation for piping systems used in industrial settings. The “air cell” design referred to a construction method in which insulating material was formed around a pipe with air pockets or channels that enhanced thermal resistance, making the product well suited for high-temperature industrial applications.

Throughout much of the twentieth century, Ruberoid Air Cell was a recognized name in the industrial insulation market. It was applied in power plants, refineries, chemical processing facilities, and manufacturing environments where maintaining consistent pipe temperatures was critical to operations. The product’s long production run reflected its widespread adoption across heavy industry during a period when asbestos-containing insulation materials were standard practice.

G-I Holdings, the entity most directly associated with Ruberoid products in litigation, traces its corporate lineage through a series of mergers and acquisitions that included the Ruberoid Company, which was eventually acquired by GAF Corporation. G-I Holdings was later incorporated as part of a corporate restructuring of GAF-related entities. This corporate history has been central to legal proceedings involving Ruberoid-branded products, as plaintiffs and their counsel worked to establish liability through connected predecessor and successor relationships.

Asbestos Content

Ruberoid Air Cell pipe insulation contained chrysotile asbestos as a primary component of its composition. Chrysotile, sometimes called white asbestos, is the most commercially used form of asbestos and was widely incorporated into thermal insulation products throughout most of the twentieth century due to its heat-resistant properties, tensile strength, and relatively low cost.

In pipe insulation products of this type, chrysotile asbestos fibers were typically blended into the insulating matrix to reinforce the material and improve its ability to withstand sustained elevated temperatures. The fibrous nature of asbestos made it an effective binder and structural component in products like Air Cell, which needed to conform to pipe surfaces while remaining durable under thermal cycling and mechanical stress.

Chrysotile asbestos is classified as a known human carcinogen by the International Agency for Research on Cancer (IARC) and is regulated under OSHA’s asbestos standards at 29 CFR 1910.1001 (general industry) and 29 CFR 1926.1101 (construction). The EPA’s Asbestos Hazard Emergency Response Act (AHERA) also addresses chrysotile-containing materials in the context of identification, abatement, and exposure management.

How Workers Were Exposed

The workers most directly at risk from Ruberoid Air Cell pipe insulation were industrial workers employed in facilities where the product was installed, maintained, repaired, or removed. Exposure pathways varied depending on the phase of the product’s life cycle in which a worker was involved.

During installation, workers handled sections of the insulation, cutting and shaping them to fit pipe runs of varying dimensions. This cutting process—whether performed with knives, saws, or abrasive tools—generated airborne asbestos-containing dust. Workers in the immediate area, as well as bystanders in the same work zone, could inhale these fibers.

Maintenance and repair activities posed an equally significant hazard. Industrial pipe systems require periodic inspection and service, and accessing underlying pipe sections often meant removing and replacing existing insulation. Disturbing aged or damaged Ruberoid Air Cell insulation released fibers that had become loosely bound over time due to thermal stress and deterioration. Workers performing this work typically did so without respiratory protection during the decades when asbestos risks were not communicated to the workforce.

Demolition and renovation work in older industrial facilities created additional exposure events. Workers tasked with tearing out insulation from decommissioned equipment or during plant upgrades would encounter large quantities of degraded asbestos-containing material. In enclosed or poorly ventilated industrial spaces, fiber concentrations could reach significant levels.

Secondary or bystander exposure was also a recognized pathway. Industrial workers who did not directly handle the insulation but worked in proximity to insulation activities—welders, pipefitters, electricians, and general laborers—could inhale fibers released by the work of others. These workers sometimes had no awareness that asbestos-containing products were being disturbed nearby.

OSHA’s current permissible exposure limit (PEL) for asbestos is 0.1 fibers per cubic centimeter of air as an eight-hour time-weighted average, with an excursion limit of 1.0 f/cc over any thirty-minute period. Work practices that were common during the production and widespread installation years of Ruberoid Air Cell would not have met these standards, and historical exposure levels in many industrial environments exceeded what is now known to present serious health risks.

Ruberoid Air Cell is a Tier 2 litigated product. There is no established asbestos bankruptcy trust fund associated with G-I Holdings from which claims for this specific product can be submitted through a structured trust process. Legal recourse for individuals harmed by exposure to this product has proceeded primarily through civil litigation in state and federal courts.

Litigation records document claims brought by industrial workers and their families alleging that exposure to Ruberoid Air Cell pipe insulation caused serious asbestos-related diseases, including mesothelioma, asbestosis, and lung cancer. Plaintiffs alleged that the manufacturers and distributors of Ruberoid-branded insulation products knew or should have known of the hazards associated with chrysotile asbestos exposure, and that they failed to adequately warn workers or take steps to reduce exposure risks.

Plaintiffs in these cases alleged that G-I Holdings and its corporate predecessors bore responsibility for the design, manufacture, and distribution of an inherently dangerous product that was sold and installed without adequate safety information. Litigation records document that corporate history—including the relationships among the Ruberoid Company, GAF Corporation, and G-I Holdings—was examined in proceedings to establish which entities bore liability for injuries caused by these products.

Individuals who believe they were exposed to Ruberoid Air Cell pipe insulation and have subsequently received a diagnosis of an asbestos-related disease should consult with a qualified asbestos litigation attorney. An attorney experienced in asbestos product liability can evaluate:

  • Work history documentation establishing presence at facilities where Ruberoid Air Cell was installed or disturbed
  • Medical records confirming an asbestos-related diagnosis such as mesothelioma, asbestosis, or asbestos-related lung cancer
  • Corporate liability chains connecting current or dissolved entities to the Ruberoid brand
  • Applicable statutes of limitations, which vary by state and typically begin running from the date of diagnosis

Because no dedicated trust fund exists for this product, potential claimants are dependent on the civil litigation system for recovery. Early consultation with legal counsel is important given the time-sensitive nature of statutes of limitations governing asbestos disease claims.